Raphaèle Séror

23.4k total citations · 4 hit papers
175 papers, 8.5k citations indexed

About

Raphaèle Séror is a scholar working on Physiology, Rheumatology and Surgery. According to data from OpenAlex, Raphaèle Séror has authored 175 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Physiology, 80 papers in Rheumatology and 52 papers in Surgery. Recurrent topics in Raphaèle Séror's work include Salivary Gland Disorders and Functions (73 papers), Systemic Lupus Erythematosus Research (45 papers) and Salivary Gland Tumors Diagnosis and Treatment (32 papers). Raphaèle Séror is often cited by papers focused on Salivary Gland Disorders and Functions (73 papers), Systemic Lupus Erythematosus Research (45 papers) and Salivary Gland Tumors Diagnosis and Treatment (32 papers). Raphaèle Séror collaborates with scholars based in France, United States and United Kingdom. Raphaèle Séror's co-authors include Xavier Mariette, Simon Bowman, Claudio Vitali, Loı̈c Guillevin, Philippe Ravaud, Xavier Mariette, Christian Pagnoux, Lindsey A. Criswell, Marc Labétoulle and Caroline H. Shiboski and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Raphaèle Séror

161 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient Cohorts

2016 1.1k citations Caroline H. Shiboski, Stephen Shiboski et al. Arthritis & Rheumatology profile →
2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome

2016 928 citations Caroline H. Shiboski, Stephen Shiboski et al. Annals of the Rheumatic Diseases profile →
EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome

2009 656 citations Raphaèle Séror, Philippe Ravaud et al. Annals of the Rheumatic Diseases profile →
The Five-Factor Score Revisited

2010 580 citations Loı̈c Guillevin, Raphaèle Séror et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Raphaèle Séror France	43	4.7k	2.9k	2.2k	1.9k	1.3k	175	8.5k
Pilar Brito‐Zerón Spain	47	3.2k 0.7×	3.3k 1.1×	1.7k 0.7×	1.1k 0.6×	909 0.7×	120	8.8k
Jacques‐Eric Gottenberg France	46	2.9k 0.6×	2.7k 0.9×	1.4k 0.6×	520 0.3×	1.0k 0.8×	163	7.1k
Hendrika Bootsma Netherlands	51	5.3k 1.1×	3.0k 1.0×	2.6k 1.1×	422 0.2×	1.2k 0.9×	245	9.0k
Simon Bowman United Kingdom	42	5.2k 1.1×	2.2k 0.8×	2.4k 1.1×	357 0.2×	1.2k 0.9×	129	8.1k
Claudio Vitali Italy	26	3.2k 0.7×	1.7k 0.6×	1.5k 0.7×	332 0.2×	825 0.6×	59	5.0k
Xavier Puéchal France	46	1.7k 0.4×	3.3k 1.1×	1.1k 0.5×	3.0k 1.6×	1.1k 0.8×	213	7.1k
Elisabeth Brouwer Netherlands	50	1.7k 0.4×	4.6k 1.6×	680 0.3×	4.5k 2.4×	514 0.4×	240	9.4k
Elke Theander Sweden	33	3.1k 0.7×	1.7k 0.6×	1.5k 0.7×	160 0.1×	642 0.5×	106	4.9k
Fotini N. Skopouli Greece	37	2.3k 0.5×	1.4k 0.5×	920 0.4×	290 0.2×	746 0.6×	98	4.3k
Pierre‐Yves Hatron France	42	1.2k 0.3×	1.7k 0.6×	1.0k 0.5×	2.0k 1.1×	2.1k 1.6×	142	5.7k

Countries citing papers authored by Raphaèle Séror

Since Specialization

Citations

This map shows the geographic impact of Raphaèle Séror's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphaèle Séror with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphaèle Séror more than expected).

Fields of papers citing papers by Raphaèle Séror

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphaèle Séror. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphaèle Séror. The network helps show where Raphaèle Séror may publish in the future.

Co-authorship network of co-authors of Raphaèle Séror

This figure shows the co-authorship network connecting the top 25 collaborators of Raphaèle Séror. A scholar is included among the top collaborators of Raphaèle Séror based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphaèle Séror. Raphaèle Séror is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Séror, Raphaèle, et al.. (2025). Association between cardiovascular risk factors and the occurrence of giant cell arteritis: a systematic review and meta-analysis. Lara D. Veeken. 64(8). 4525–4538.

Séror, Raphaèle, et al.. (2024). Estimated prevalence, incidence and healthcare costs of Sjögren’s syndrome in France: a national claims-based study. RMD Open. 10(1). e003591–e003591. 7 indexed citations

Berrouiguet, Sofian, Dewi Guellec, Guillermo Carvajal Alegria, et al.. (2024). Development of a web-based ecological momentary assessment tool to measure day-to-day variability of the symptoms in patients with Sjögren’s disease. RMD Open. 10(4). e004526–e004526.

Debray, Marie‐Pierre, Antoine Beurnier, Pierre‐Antoine Juge, et al.. (2024). Characterisation of airway disease associated with Sjögren disease. RMD Open. 10(1). e003866–e003866. 1 indexed citations

Hubbard, Jesse J., Kim Campbell, Kathy L. Sivils, et al.. (2023). POS1130 DESIGNING OF A PHASE 2, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO ASSESS THE EFFICACY AND SAFETY OF NIPOCALIMAB, AN FCRN INHIBITOR, IN ADULTS WITH PRIMARY SJÖGREN'S SYNDROME. Annals of the Rheumatic Diseases. 82. 892–893. 1 indexed citations

Kawka, Lou, Nicolás Meyer, Tao Ye, et al.. (2023). Association Between Bruton's Tyrosine Kinase Gene Overexpression and Risk of Lymphoma in Primary Sjögren's Syndrome. Arthritis & Rheumatology. 75(10). 1798–1811. 3 indexed citations

Tarn, Jessica, John Casement, Lauren J Scott, et al.. (2023). Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: proteomic and network analysis. Annals of the Rheumatic Diseases. 83(1). 88–95. 9 indexed citations

Beydon, Maxime, Sandrine Pinto, Yann De Rycke, et al.. (2023). Risk of cancer for patients with rheumatoid arthritis versus general population: a national claims database cohort study. The Lancet Regional Health - Europe. 35. 100768–100768. 29 indexed citations

Beydon, Maxime, Raphaèle Séror, Véronique Le Guern, et al.. (2023). Impact of patient ancestry on heterogeneity of Sjögren’s disease. RMD Open. 9(1). e002955–e002955. 6 indexed citations

10.

Séror, Raphaèle, Gabriel Baron, Marine Camus, et al.. (2022). Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 81(7). 979–989. 42 indexed citations

11.

Morel, Jacques, Anne Tournadre, Jérémie Sellam, et al.. (2021). Practical management of patients on anti-IL6R therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine. 88(4). 105221–105221.

12.

Lendrem, Dennis, James Wason, Jessica Tarn, et al.. (2021). Revisiting the JOQUER trial: stratification of primary Sjögren’s syndrome and the clinical and interferon response to hydroxychloroquine. Rheumatology International. 41(9). 1593–1600. 16 indexed citations

13.

Collins, Michael, et al.. (2020). Articular manifestations in patients with inflammatory bowel disease treated with vedolizumab. Lara D. Veeken. 59(11). 3275–3283. 13 indexed citations

14.

Paoletti, Audrey, Julien Rohmer, Bineta Ly, et al.. (2019). Monocyte/Macrophage Abnormalities Specific to Rheumatoid Arthritis Are Linked to miR-155 and Are Differentially Modulated by Different TNF Inhibitors. The Journal of Immunology. 203(7). 1766–1775. 53 indexed citations

15.

Abbara, Salam, Raphaèle Séror, Julien Henry, et al.. (2019). Anti-RNP positivity in primary Sjögren’s syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement. RMD Open. 5(2). e001033–e001033. 21 indexed citations

16.

Shiboski, Caroline H., Stephen Shiboski, Raphaèle Séror, et al.. (2016). 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 76(1). 9–16. 928 indexed citations breakdown →

17.

Nocturne, Gaëtane, Wan‐Fai Ng, Véronique Le Guern, et al.. (2015). Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome. Arthritis & Rheumatology. 68(4). 977–985. 128 indexed citations

18.

Bafeta, Aïda, Ludovic Trinquart, Raphaèle Séror, & Philippe Ravaud. (2014). Reporting of results from network meta-analyses: methodological systematic review. BMJ. 348(mar11 5). g1741–g1741. 148 indexed citations

19.

Bérezné, A., Raphaèle Séror, S. Morell‐Dubois, et al.. (2010). Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers. Arthritis Care & Research. 63(2). 277–285. 81 indexed citations

20.

Séror, Raphaèle, Florence Tubach, Gabriel Baron, François Guillemin, & Philippe Ravaud. (2009). Measure of function in rheumatoid arthritis: individualised or classical scales?. Annals of the Rheumatic Diseases. 69(1). 97–101. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact